Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases

Abstract

Abstract Chronic inflammatory systemic diseases are the result of the body's immune imbalance, with a long course and recurring episodes. Immunosuppressants are the main treatment, but not all patients respond well to it. Being capable of both self-renewal and differentiation into multiple tissue cells and low immunogenicity, mesenchymal stem cell is a promising treatment for chronic inflammatory systemic diseases. In this article, we describe the research progress and clinical application of mesenchymal stem cells in chronic inflammatory systemic diseases and look for influencing factors and biomarkers that can predict the outcome of patient with mesenchymal stem cell transplantation.

Keywords

• Mesenchymal stem cells
• Prognosis
• Biomarkers
• Rheumatoid arthritis
• Systemic lupus erythematosus
• Inflammatory bowel disease